01 1Teva Pharmaceutical Industries
01 1REMIMAZOLAM BESYLATE
01 1Israel
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-08-29
Pay. Date : 2024-05-01
DMF Number : 39813
Submission : 2024-05-30
Status : Active
Type : II
20
Teva Pharmaceutical Industries Ltd, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is REMIMAZOLAM BESYLATE, with a corresponding US DMF Number 39813.
Remarkably, this DMF maintains an Active status since its submission on May 30, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 29, 2024, and payment made on May 01, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
